Alveolar rhabdomyosarcoma originating from the uterine cervix

Eur J Gynaecol Oncol. 2011;32(2):196-8.


Cervical alveolar rhabdomyosarcoma is a rare condition associated with poor prognosis. An 18-year-old patient presented with vaginal bleeding and a protruding mass from the vagina. Biopsy of the mass revealed alveoler rhabdomyosarcoma (ARMS), and radiological evaluation demonstrated that it originated from the uterine cervix. First, Wertheim's operation was carried out followed by four cycles of vincristine, actinomycine-D, ifosfamide (VAI) chemotherapy. However, the disease relapsed within three months, and the patient died of disease progression. Despite combination treatment, we could not achieve a desirable survival advantage in ARMS. Future studies may unveil the genomic profile of this rare condition, leading to invention of targeted therapies, which is the emerging trend in the treatment of sarcomas.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Fatal Outcome
  • Female
  • Humans
  • Hysterectomy
  • Ifosfamide / therapeutic use
  • Rhabdomyosarcoma, Alveolar / pathology*
  • Rhabdomyosarcoma, Alveolar / therapy
  • Uterine Cervical Neoplasms / pathology*
  • Uterine Cervical Neoplasms / therapy
  • Vincristine / therapeutic use


  • Vincristine
  • Ifosfamide